Arbutus Cash And Short Term Investments from 2010 to 2024
| ABUS Stock | USD 3.46 0.01 0.29% |
Cash And Short Term Investments | First Reported 2007-06-30 | Previous Quarter 142 M | Current Value 127.8 M | Quarterly Volatility 61 M |
Check Arbutus Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arbutus Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 701.5 K or Selling General Administrative of 12.2 M, as well as many indicators such as Price To Sales Ratio of 13.01, Dividend Yield of 0.0529 or PTB Ratio of 3.72. Arbutus financial statements analysis is a perfect complement when working with Arbutus Biopharma Valuation or Volatility modules.
Arbutus | Cash And Short Term Investments |
Latest Arbutus Biopharma's Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Arbutus Biopharma Corp over the last few years. Short Term Investments is an account in the current assets section of Arbutus Biopharma Corp balance sheet. This account contains Arbutus Biopharma investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Arbutus Biopharma Corp fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Arbutus Biopharma's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arbutus Biopharma's overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Arbutus Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 101,478,035 | |
| Geometric Mean | 76,672,683 | |
| Coefficient Of Variation | 50.68 | |
| Mean Deviation | 41,760,358 | |
| Median | 123,268,000 | |
| Standard Deviation | 51,431,667 | |
| Sample Variance | 2645.2T | |
| Range | 174.8M | |
| R-Value | 0.58 | |
| Mean Square Error | 1893.7T | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | 6,658,812 | |
| Total Sum of Squares | 37033T |
Arbutus Cash And Short Term Investments History
About Arbutus Biopharma Financial Statements
Arbutus Biopharma shareholders use historical fundamental indicators, such as Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Arbutus Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Arbutus Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Arbutus Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 126 M | 73.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.